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doi:10.1016/j.jhep.2008.06.007New signs and old applications of echo-color-Doppler should
always be compared to a gold standardTo the Editor:
We thank our colleagues for the comments to our
paper, which allow us to better clarify some aspects
regarding the US diagnosis of liver involvement in
hereditary hemorrhagic teleangiectasia (HHT)
patients.
In our study, we described a new Doppler sign, called
‘color-spot’, particularly suitable for identifying small
hepatic arterio-venous malformations (HAVMs) and
veriﬁed its accuracy using multislice CT (MSCT) as gold
standard [1]. Moreover, we clearly distinguished the col-
or-spots found in the peripheral subcapsular region of
the liver from ‘hepatic hypervascularization’, a sign previ-
ously reported by Caselitz et al. [2]. Both are suggestive
of small HAVMs and provide a greater diagnostic sensi-
tivity for HAVMs in HHT when compared to previ-
ously published extrahepatic parameters.
It must be emphasized that the diagnostic sensitivity
and accuracy of previous ultrasound (US) ﬁndings [2–
4] cannot be deﬁned since their results were not system-
atically compared to a gold standard; in fact, Doppler-
negative HHT patients have never been systematically
compared with other techniques. Ours is the ﬁrst con-
trolled study to assess the diagnostic accuracy of Dopp-
ler US for diagnosis of HAVMs in HHT with respect to
MSCT as a reference technique. According to Buscariniet al., the use of CT as gold standard is debatable, as we
employed a 4-detector CT scanner which is not the best
available technology; however, these authors did not
consider that our prospective study was conducted over
a four-year period. Having initiated our study with a 4-
detector CT scan and in order to avoid inter-equipment
variability [5], we preferred to prospectively study a
large patient sample maintaining the same methodology,
even if meanwhile a more sophisticated 16-detector scan
had become available (moreover, our HHT-experienced
radiologists have not found any diﬃculties in identifying
tiny vascular abnormalities with both CT scanner
systems).
The two signs (color-spot described by our group and
peripheral hypervascularization reported by Buscarini
et al. [4]) are two distinct echo-color-Doppler parame-
ters. The color-spot sign appears in the presence of iso-
lated spotty-like images with a high blood-ﬂow
velocity and a resistive index (RI) less than 0.45. It cor-
responds to a point on a very small peripheral tortuous
arterial vessel where, due to a Doppler angle close to
zero, the high Doppler frequency shift overcomes the
threshold of detection, thus giving rise to a visible
spotty-like image (whereas the remaining tract of the
vessel, characterized by an unfavourable Doppler angle,
undergoes a reduction in the intensity of the ultrasound
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peculiar of very small vessels while tortuous vessels of
larger size (such as 1st and 2nd degree branches of the
hepatic artery, often protruding into the peripheral liver
region) can be detected in their entire length with color
Doppler, occasionally as a ‘spider-like’ sign, correspond-
ing to the ‘‘peripheral hypervascularization” described by
Buscarini et al. [4]. Therefore, the images of peripheral
hypervascularization should not be considered as a
superimposition of our color-spot images. Hence, our
color-spot is a new Doppler sign and not, as suggested
by these authors, merely a previously-reported sign with
a new name. In fact, in our cohort, we can aﬃrm that
the majority of HAVM-patients (122/128, 95%) received
a positive Doppler-based diagnosis by means of the new
color-spot sign, thus reaching a prevalence similar to
that detected by MSCT (84%). Given the very small size
of many liver AVMs [6], we can also conclude that color-
spots represent a sign revealing the presence of small
liver AVMs even earlier than Buscarini’s peripheral
hypervascularization, since the latter sign requires the
visualization of the entire vessel tract to be detected
(and consequently only abnormalities involving larger
vessels can be depicted).
We clearly deﬁned the term hypervascularization as a
‘‘highly evident appearance of the main hepatic artery
branches in the portal spaces; the higher ﬂow velocities
generated by the shunts determine tortuosity and
enlargement of these vessels, evidenced by color-Dopp-
ler as tones varying in intensity from bright red to yellow
orange” [1]. In the majority of our patients, this sign was
observed in absence of any extrahepatic signs or intra-
hepatic B-mode-signs. Therefore, only in a few cases
was it concomitant with evident hepatic artery (HA)
dilatation, strongly increased HA ﬂow velocity and
other B-mode-signs included in grades 2–4 of the classi-
ﬁcation reported by Buscarini [4]. Rather, hypervascu-
larization seems to even indicate an only moderate
increase of blood ﬂow velocity in HA branches which
might be secondary to numerous subcapsular, low-RI,
micro-AVMs with little haemodynamic impact, which
accounts for its use as a sign suggestive of small AVMs.Table 1
Color-spot, hypervascularization and hepatic artery RI (<0.55) in MSCT+
Parameters HA > 7 HA > 6/67
MSCT+ patients 46 19
Color-spot 46 19
Hypervascularization 46 18
HA-RI < 0.55 12 2
MSCT patients 1 2
Color-spot 0 1
Hypervascularization 0 1
HA-RI < 0.55 0 0
Abbreviations: MSCT = multislice computer tomography; RI = resistiveTherefore, it cannot always be suggestive of ‘‘obvious,
prominent vascular abnormalities”.
Our results clearly show that intra-hepatic signs (both
color-spots and hypervascularization) have a better sensi-
tivity and accuracy than extrahepatic ultrasonography
parameters (95–82% vs 40%, and 90–81% vs 50%,
respectively). Regarding this point, Buscarini et al.
noted that we utilized the cut-oﬀ values reported by Cas-
elitz et al. [2] particularly the HA diameter of >7 mm,
and stated that this cut-oﬀ might be aﬀected by a selec-
tion bias, and, consequently, determine ‘‘the risk of a
low diagnostic sensitivity when applied to the screening
of a general HHT population”. The use of a lower cut-
oﬀ is suggested, as proposed in their classiﬁcation,
(HA > 6 mm in grade 1 and HA diameter >5 mm–
<6 mm in grade 0+) [4]. Therefore, to dispel their con-
cerns, in the present letter we report our data on intra-
hepatic signs with respect to the HA diameter, taking
into account both cut-oﬀs (Caselitz [2] and Buscarini
[4], Table 1).
As shown, the use of a lower hepatic artery diameter
cut-oﬀ (>6 mm, grade 1) would not determine a signiﬁ-
cant increase in HAVM-positive patients (from 46/128
to 65/128 pts), and consequently in the sensitivity of
HAVM detection of our cohort (from 35% to 50% sen-
sitivity). Utilizing an even lower cut-oﬀ (>5 mm, grade
0+) would deﬁnitely permit an increase in HAVM-posi-
tive patients (from 65/128 to 104/128 pts), and thus in
the sensitivity (although to a lesser extent than the in-
tra-hepatic parameters, 80% for HA diameter vs 95%
for color-spot), but would also determine a decrease in
speciﬁcity and accuracy (64% and 77% for HA diameter
vs 68% and 90% for color-spot), given the evident over-
lapping with MSCT-negative patients (together with
non-HHT subjects and non-HHT-related cirrhotic
patients).
On the other hand, to avoid such a decrease in spec-
iﬁcity, Buscarini et al. [4] included their grade 0+ among
the grid of parameters also requiring the detection of an-
other extrahepatic parameter (namely, hepatic artery
resistive index (HA-RI) < 0.55). In the table, the results
based on HA-RI show that a very low sensitivity value/MSCT patients according to HA diameter cut-oﬀ (mm)
HA > 5/66 HA 6 5 Total
39 24 128
36 21 122
29 13 106
4 4 22
6 16 25
3 5 9
3 2 6
2 1 3
index; HA = hepatic artery.
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without dilatation of HA (using both Caselitz and Bus-
carini’s thresholds) had both color-spots and hypervascu-
larization, thus further supporting our statement that
intra-hepatic parameters have a better sensitivity and
accuracy than extrahepatic ultrasonography parameters
due to their ability to permit the diagnosis of even very
small AVMs in their early stage of development. Evi-
dently the presence of more severe vascular involvement
determines an angiodynamic remodelling and gross
abnormalities which can be detected on B-mode ultraso-
nographic study (mainly enlargement of HA in the
extrahepatic tract and ‘double channel aspect’ in the
portal spaces).
In conclusion, in this ﬁrst controlled, prospective
study, we have demonstrated that the diagnosis of
HAVMs in HHT can reliably be made by merely using
intra-hepatic parameters and does not require evidence
of extrahepatic abnormalities. The latter are useful to
grade the haemodynamic impact of HAVMs and the
possible eﬀect on liver angioarchitecture and clinical sig-
niﬁcance. We disagree with Dr. Buscarini’s ﬁnal com-
ment in which she states that ‘‘Doppler US diagnosis
of liver VMs in HHT requires a combination of extrahe-
patic and intra-hepatic ﬁndings, which can provide a
diagnostic accuracy ranging between 95% and 99% for
diﬀerent observers” [7] because in the absence of a stan-
dard reference technique, data on sensitivity and accu-
racy cannot be considered reliable.
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doi:10.1016/j.jhep.2008.06.008ia: Diﬀerent from European rates?To the Editor:
We have read with much interest the review by Este-
ban et al. on the changing epidemiology of hepatitis C
virus (HCV) infection in Europe [1]. Hepatitis C has be-
come a major public health problem worldwide with sig-
niﬁcant geographical and temporal heterogeneity. The
burden of HCV infection in Romania is an area of great
concern for at least three main reasons: (1) based on
scarce and outdated information, Romania is consid-
ered the European country with the highest prevalence
rate (double that of Spain or Greece, for example); (2)
Romania is one of the most important sources of mi-grant population towards Western Europe, in particular
to countries such as Spain and Italy, therefore altering
the decreasing trend of HCV prevalence in these coun-
tries; (3) last but not least, there is an urgent need for
a national strategy for the active detection and control
of the silent epidemic of HCV-infected population in
Romania. Although HCV infection is a major public
health problem in Romania, its prevalence in the general
population and its routes of transmission are largely un-
known. Before 1989, during the communist era, data on
the prevalence of viral hepatitis in Romania were scarce.
The reported prevalence of HCV infection in Romania
